| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| eszopiclone | gamma-aminobutyric acid receptor subunit alpha-1 | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.26 | approved,investigational | potentiator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.26 | approved,investigational | positive allosteric modulator |
| eszopiclone | gamma-aminobutyric acid receptor subunit alpha-1 | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.26 | approved,investigational | potentiator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.26 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gamma-aminobutyric acid receptor subunit alpha-2 | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved,investigational | agonist,positive modulator |
| eszopiclone | gamma-aminobutyric acid receptor subunit alpha-2 | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved,investigational | agonist |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved,investigational | positive allosteric modulator |
| eszopiclone | gamma-aminobutyric acid receptor subunit alpha-3 | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved,investigational | agonist |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved,investigational | positive allosteric modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gamma-aminobutyric acid receptor subunit alpha-3 | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.17 | approved,investigational | agonist,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gamma-aminobutyric acid receptor subunit alpha-5 | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | approved,investigational | agonist,positive modulator |
| eszopiclone | gamma-aminobutyric acid receptor subunit alpha-5 | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | approved,investigational | agonist |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | approved,investigational | positive allosteric modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.18 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved,investigational | positive allosteric modulator,positive modulator |
| eszopiclone | translocator protein | NA | Successful target | TTD , DGIDB | Sleeplessness[MeSHID:D007319] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.62 | approved | unknown |
| click here to return to the previous page | ||||||||